Recruiting A Study to Find a Suitable Dose of Exl-111 for Further Research NCT07356713 Conditions Allergic Disease Locations CMAX — Adelaide, South Australia, Australia View Trial Details
Recruiting Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis NCT07316465 Conditions Allergic Disease, Atopic Dermatitis (AD), Auto-Immunity, +15 more Locations Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB) — Jette, Brussels Capital, Belgium View Trial Details
Not Yet Recruiting Screening and Management of Adults With Asthma and Allergic Diseases NCT07523724 Conditions Allergic Disease, Asthma, Bronchial Diseases, +7 more Locations Not specified View Trial Details
Completed A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases NCT05960708 Conditions Allergic Disease, Chronic Disease, Chronic Inducible Urticaria, +13 more Locations Hallym University Sacred Heart Hospital — Anyang-si, Gyeonggi-do, South Korea Hallym University Dongtan Sacred Heart Hospital — Hwaseong-si, Gyeonggi-do, South Korea CHA Bundang Medical Center — Seongnam-si, Gyeonggi-do, South Korea Seoul National University Bundang Hospital — Seongnam-si, Gyeonggi-do, South Korea View more locations Show fewer locations Loading locations... View Trial Details
